BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37432852)

  • 41. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
    Aishima S; Oda Y
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification.
    Lieshout R; Faria AVS; Peppelenbosch MP; van der Laan LJW; Verstegen MMA; Fuhler GM
    Mol Med; 2022 Jun; 28(1):74. PubMed ID: 35764936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrahepatic Cholangiocarcinoma in a Background of Biliary Adenofibroma: A Rare Entity.
    Agarwal J; Patkar S; Rabade K; Bal M; Goel M
    J Gastrointest Cancer; 2023 Dec; 54(4):1359-1361. PubMed ID: 36995560
    [No Abstract]   [Full Text] [Related]  

  • 45. Accepting Our Technical Limitations: Intraoperative Bile Duct Margin in Perihilar Cholangiocarcinoma Reflects Disease Biology.
    Concors SJ; Snyder RA
    Ann Surg Oncol; 2023 Jun; 30(6):3180-3181. PubMed ID: 36737529
    [No Abstract]   [Full Text] [Related]  

  • 46. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.
    Sirica AE; Nathanson MH; Gores GJ; Larusso NF
    Hepatology; 2008 Dec; 48(6):2040-6. PubMed ID: 18855901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transpapillary biliary biopsy for early stage cholangiocarcinoma of the distal common bile duct.
    Asada M; Yazumi S; Yoshimoto T; Tamaki H; Matsuura M; Hasegawa K; Uenoyama Y; Hisatsune H; Nishio A; Chiba T
    Gastrointest Endosc; 2006 Jul; 64(1):125-6; discussion 126. PubMed ID: 16813820
    [No Abstract]   [Full Text] [Related]  

  • 48. Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report.
    Carson SW; Craven KE; Nauen D; Montemayor K; Yarchoan M; Burns WR; Merlo CA; West NE
    BMC Pulm Med; 2020 Nov; 20(1):298. PubMed ID: 33198722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Balsano C; Conti B; Arciello M
    Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009
    [No Abstract]   [Full Text] [Related]  

  • 51. Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis--a new histologic subtype for further investigation.
    Bae JY; Park YN; Nakanuma Y; Lee WJ; Kim JY; Park C
    Hepatogastroenterology; 2002; 49(45):628-30. PubMed ID: 12063956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
    Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
    Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping.
    Lee HS; Han DH; Cho K; Park SB; Kim C; Leem G; Jung DE; Kwon SS; Kim CH; Jo JH; Lee HW; Song SY; Park JY
    Nat Commun; 2023 Jan; 14(1):237. PubMed ID: 36646721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary clear cell carcinoma of hilar bile duct: a case report.
    Gu L; Jiang CH; Xu Q; Liu Q; Luo M; Wu ZY
    J Dig Dis; 2010 Feb; 11(1):63-5. PubMed ID: 20132433
    [No Abstract]   [Full Text] [Related]  

  • 56. Intrahepatic cholangiocarcinoma arising in Caroli's disease.
    Jang MH; Lee YJ; Kim H
    Clin Mol Hepatol; 2014 Dec; 20(4):402-5. PubMed ID: 25548748
    [No Abstract]   [Full Text] [Related]  

  • 57. Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern.
    Choe JY; Kim H
    Clin Mol Hepatol; 2014 Jun; 20(2):214-7. PubMed ID: 25032189
    [No Abstract]   [Full Text] [Related]  

  • 58. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.
    De Siervi S; Turato C
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
    Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
    Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biliary tumors of the liver.
    Colombari R; Tsui WM
    Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.